Evaluating a Structural and Behavioral HIV Risk Reduction Program for Black Men (MEN Count)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01694121|
Recruitment Status : Active, not recruiting
First Posted : September 26, 2012
Last Update Posted : November 24, 2017
|Condition or disease||Intervention/treatment||Phase|
|HIV||Behavioral: MEN Count Behavioral: Comparison||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||455 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Evaluating a Structural and Behavioral HIV Risk Reduction Program for Black Men|
|Actual Study Start Date :||March 2013|
|Actual Primary Completion Date :||April 2017|
|Estimated Study Completion Date :||May 2018|
Experimental: MEN Count
3 session HIV intervention including a) HIV risk reduction, inclusive of gender equity and healthy relationship counseling and b) case management support for stable employment and housing.
Behavioral: MEN Count
The MEN Count model integrates HIV risk reduction and gender-equity counseling with housing and employment case management via multiple one-on-one sessions delivered by a peer case manager over 60-90 day period.
Active Comparator: Comparison
An attention comparison program similar to the MEN Count intervention in structure (3 one-on-one sessions delivered over 60-90 days) but focused on stress reduction and healthy lifestyle.
general health intervention for men, not inclusive of HIV or relationship health
- condom use/unprotected sex [ Time Frame: up to 12 month follow-up ]behavioral assessment of the ratio of protected to total number of sex episodes
- HIV/STI testing [ Time Frame: 6 and 12 month follow-up ]HIV and STI testing via blood and urine tests
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01694121
|United States, District of Columbia|
|George Washington University|
|Washington, District of Columbia, United States, 20052|
|Principal Investigator:||Anita Raj, PhD||UCSD|
|Principal Investigator:||Lisa Bowleg, PhD||George Washington University|